Ugur Sahin, BioNTech CEO (Jan Haas/picture-alliance/dpa/AP Images)
December 4, 2020 10:25 AM EST
People
R&D

BioN­Tech chief Ugur Sahin gains star sta­tus in the ex­clu­sive Cov­il­lion­aire club

John Carroll

Editor & Founder

Rid­ding the world of Covid-19 is a lu­cra­tive en­ter­prise.

As an­a­lysts divvy up the multi­bil­lion-dol­lar re­wards in line for the lead­ers in the race to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Can Bill An­der­son save Bay­er?

Drug pol­i­cy vet­er­an at CMS to de­part on Fri­day

Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back, as Ver­tex walks away from pact

FDA meet­ing to pick next win­ter's flu shot is can­celed, in omi­nous sign for US vac­cine pol­i­cy

CDC is in­ves­ti­gat­ing five hos­pi­tal­iza­tions af­ter use of Val­ne­va’s chikun­gun­ya vac­cine

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times